Hildenbrand R - Search Results

1

Tumor stroma is the predominant uPA-, uPAR-, PAI-1-expressing tissue in human breast cancer: prognostic impact.

Hildenbrand R, Schaaf A, Dorn-Beineke A, Allgayer H, Sütterlin M, Marx A, Stroebel P. Hildenbrand R, et al. Histol Histopathol. 2009 Jul;24(7):869-77. doi: 10.14670/HH-24.869. Histol Histopathol. 2009. PMID: 19475533

2

Amplification of the urokinase-type plasminogen activator receptor (uPAR) gene in ductal pancreatic carcinomas identifies a clinically high-risk group.

Hildenbrand R, Niedergethmann M, Marx A, Belharazem D, Allgayer H, Schleger C, Ströbel P. Hildenbrand R, et al. Am J Pathol. 2009 Jun;174(6):2246-53. doi: 10.2353/ajpath.2009.080785. Epub 2009 May 12. Am J Pathol. 2009. PMID: 19435784 Free PMC article.

3

Modulators of the urokinase-type plasminogen activation system for cancer.

Hildenbrand R, Allgayer H, Marx A, Stroebel P. Hildenbrand R, et al. Expert Opin Investig Drugs. 2010 May;19(5):641-52. doi: 10.1517/13543781003767400. Expert Opin Investig Drugs. 2010. PMID: 20402599 Review.

4

The urokinase-system--role of cell proliferation and apoptosis.

Hildenbrand R, Gandhari M, Stroebel P, Marx A, Allgayer H, Arens N. Hildenbrand R, et al. Histol Histopathol. 2008 Feb;23(2):227-36. doi: 10.14670/HH-23.227. Histol Histopathol. 2008. PMID: 17999379 Review.

5

The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.

Hildenbrand R, Schaaf A. Hildenbrand R, et al. Int J Oncol. 2009 Jan;34(1):15-23. Int J Oncol. 2009. PMID: 19082473

6

Urokinase-type plasminogen activator induces proliferation in breast cancer cells.

Gandhari M, Arens N, Majety M, Dorn-Beineke A, Hildenbrand R. Gandhari M, et al. Among authors: hildenbrand r. Int J Oncol. 2006 Jun;28(6):1463-70. Int J Oncol. 2006. PMID: 16685447

7

Validation of immunolocalization of the urokinase receptor expression in ductal carcinoma in situ of the breast: comparison with detection by non-isotopic in-situ hybridization.

Hildenbrand R, Leitz M, Magdolen V, Luther T, Albrecht S, Graeff H, Stutte HJ, Bleyl U, Schmitt M. Hildenbrand R, et al. Histopathology. 2000 Jun;36(6):499-504. doi: 10.1046/j.1365-2559.2000.00899.x. Histopathology. 2000. PMID: 10849091

8

Phenprocoumon-induced hepatitis as an immunologically mediated drug allergic complication of antithrombotic therapy.

Dorn-Beineke A, Hassan AW, Bräutigam J, Hildenbrand R, Dempfle CE, Schwab M. Dorn-Beineke A, et al. Among authors: hildenbrand r. Thromb Haemost. 2003 Dec;90(6):1210-3. Thromb Haemost. 2003. PMID: 14652659 No abstract available.

9

Protein and mRNA expression of uPAR and PAI-1 in myoepithelial cells of early breast cancer lesions and normal breast tissue.

Hildenbrand R, Arens N. Hildenbrand R, et al. Br J Cancer. 2004 Aug 2;91(3):564-71. doi: 10.1038/sj.bjc.6601990. Br J Cancer. 2004. PMID: 15226768 Free PMC article.

10

Urokinase plasminogen activator receptor (CD87) expression of tumor-associated macrophages in ductal carcinoma in situ, breast cancer, and resident macrophages of normal breast tissue.

Hildenbrand R, Wolf G, Böhme B, Bleyl U, Steinborn A. Hildenbrand R, et al. J Leukoc Biol. 1999 Jul;66(1):40-9. doi: 10.1002/jlb.66.1.40. J Leukoc Biol. 1999. PMID: 10410988

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters